Barriers to optimal care for patients with coexisting substance use and mental health disorders

Australian and New Zealand Journal of Psychiatry

Volumn 36, Issue 6, 2002, Pages 792-799

  Todd, Fraser C ^a   Sellman, J Douglas ^a   Robertson, Paul J ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Cannabis; Drug and alcohol; Dual diagnosis; Psychosis

Indexed keywords

ARTICLE; COMORBIDITY; CONSULTATION; EXPERIENCE; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HUMAN; INFORMATION PROCESSING; LIFE EVENT; MEDICAL ASSESSMENT; MEDICAL EXPERT; MEDICAL RESEARCH; MENTAL DISEASE; MENTAL HEALTH; MENTAL HEALTH SERVICE; NEW ZEALAND; PATIENT CARE; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; QUALITATIVE ANALYSIS; SUBSTANCE ABUSE; ADDICTION; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGICAL ASPECT;

DIAGNOSIS, DUAL (PSYCHIATRY); FOCUS GROUPS; HUMANS; MENTAL DISORDERS; NEW ZEALAND; PATIENT CARE; PATIENT CARE MANAGEMENT; SUBSTANCE-RELATED DISORDERS;

EID: 0036916444     PISSN: 00048674     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1614.2002.01049.x     Document Type: Article

References (27)

1. Todd FC, Sellman JD, Robertson PJ. The assessment and management of people with co-existing substance use and mental health disorders. Wellington: ALAC, 1999.
2. Schuckit MA. Genetic and clinical implications of alcoholism and affective disorder. American Journal of Psychiatry 1986; 143:140-147.
3. Reich LH, Davies RK, Himmelhoch JM. Excessive alcohol use in manic-depressive illness. American Journal of Psychiatry 1974; 131:83-86.
4. Feinman JA, Dunner DL. The effect of alcohol and substance abuse on the course of bipolar affective disorder. Journal of Affective Disorders 1996; 37:43-49.
5. Keller MB, Lavori PW, Coryell W et al. Differential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness. Journal of the American Medical Association 1986; 255:3138-3142.
6. Tien AY, Anthony JC. Epidemiological analysis of alcohol and drug use as risk factors for psychotic experiences. Journal of Nervous and Mental Disease 1990; 178:473-480.
7. Linszen DH, Dingemans PM, Lenior ME. Cannabis abuse and the course of recent-onset schizophrenic disorders. Archives of General Psychiatry 1994; 51:273-279.
8. Gruber AJ, Pope HJ, Brown ME. Do patients use marijuana as an antidepressant? Depression 1996; 4:77-80.
9. McLellan AT, Childress AR, Griffith J, Woody GE. The psychiatrically severe drug abuse patient: methadone maintenance or therapeutic community? American Journal of Drug and Alcohol Abuse 1984; 10:77-95.
10. Rounsaville BJ, Kosten TR, Weissman MM, Kleber HD. Prognostic significance of psychopathology in treated opiate addicts: a 2.5 year follow-up study. Archives of General Psychiatry 1986; 43:739-745.
11. Gill K, Nolimal D, Crowley TJ. Antisocial personality disorder, HIV risk behaviour and retention in methadone maintenance therapy. Drug and Alcohol Dependence 1992; 30:247-252.
12. Brooner RK, Greenfield L, Schmidt CW, Bigelow GE. Antisocial personality disorder and HIV infection among intravenous drug abusers. American Journal of Psychiatry 1993; 150:53-58.
13. Regier DA, Farmer ME, Rae DS et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiological Catchment Area (ECA) Study. Journal of the American Medical Association 1990; 264:2511-2518.
14. Wittchen H, Bronisch T. Alcohol use, abuse and dependence in West Germany. Lifetime and six month prevalence in the Munich follow-up study. In: Helzer JE, Canino GJ, eds. Alcoholism in North America, Europe and Asia. New York: Oxford University Press, 1992; 159-181.
15. Bland RC, Newman SC, Orn H. Alcohol abuse and dependence in Edmonton, Canada. In: Helzer JE, Canino GJ, eds. Alcoholism in North America, Europe and Asia. New York: Oxford University Press, 1992; 97-112.
16. Russell JM, Newman SC, Bland RC. Drug abuse and dependence. Acta Psychiatrica Scandinavica 1995; 376 (Suppl):54-62.
17. Helzer JE, Pryzbeck TR. The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment. Journal of Studies on Alcohol 1988; 49:219-224.
18. Myers JK, Weissman MM, Tischler GL et al. Six-month prevalence of psychiatric disorders in three communities 1980-82. Archives of General Psychiatry 1984; 41:959-967.
19. Tomasson K, Vaglum P. A nationwide representative sample of treatment-seeking alcoholics: a study of psychiatric comorbidity. Acta Psychiatrica Scandinavica 1995; 92:378-385.
20. Miller N. Psychiatric comorbidity: occurrence and treatment. Alcohol and Health Research World 1994; 18:261-264.
21. Goff DC, Henderson DC, Amico E. Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects. American Journal of Psychiatry 1992; 149:1189-1194.
22. Chong SA, Choo HL. Smoking among Chinese patients with schizophrenia. Australian and New Zealand Journal of Psychiatry 1996; 309:350-353.
23. Drake RE, Bartels SJ, Teague GB, Noordsy DL, Clark RE. Treatment of substance abuse in severely mentally ill patients. Journal of Nervous and Mental Disease 1993; 181:606-611.
24. Mowbray CT, Solomon M, Ribisl KM et al. Treatment for mental illness and substance abuse in a public psychiatric hospital. Successful strategies and challenging problems. Journal of Substance Abuse Treatment 1995; 12:129-139.
25. Shumway DL. Can managed behavioural health care plans serve the severely mentally ill? Tomorrow 1994: March/April:41-48.
26. Carey KJ. Substance use reduction in the context of outpatient psychiatric treatment. Community Mental Health Journal 1996; 32:291-306.
27. Osher FC, Kofoed LL. Treatment of patients with psychiatric and psychoactive substance abuse disorders. Hospital and Community Psychiatry 1989; 40:1025-1030.